Board Appointments

ZAGENO, Chairman

ZAGENO is a feature-rich digital marketplace designed to facilitate intelligent, streamlined purchasing decisions for scientist in bio-pharma R+D. ZAGENO offers independent and relevant bench knowledge. Scientists identify and digitally purchase critical products for their experiments more reliably, faster, and cheaper - thus driving down the time & cost to scientific breakthrough.

Javara, Inc., Board Member

Javara provides clinical research access for patients at the point of care by embedding staff and infrastructure into large healthcare organizations, resulting in greater access to cutting-edge innovations while expediting FDA approval through reliable, robust data.

Rein Therapeutics, Chairman

Rein Therapeutics is a clinical-stage biopharmaceutical company focused on developing new therapies for orphan pulmonary and fibrosis indications. Known for their first-in-class medicines, including LTI-03 for idiopathic pulmonary fibrosis (IPF) and LTI-01 for loculated pleural effusion (LPE).

Health & Wellness Partners, Board Member

Health & Wellness Partners is a leading provider of medical communications solutions to global life sciences companies. HWP currently provides three synergistic service offerings: medical affairs, medical marketing and speaker bureau. Each service offering is seeded in expert strategy, scientific content and proprietary technology enabling solutions that allow HWP to deliver tailored, high-impact educational engagements.

McLean Hospital, Trustee

McLean is a national leader in psychiatric care, research, and education and is the largest psychiatric teaching hospital of Harvard Medical School. McLean Hospital is part of the Mass General Brigham (MGB) healthcare system in Boston. Staff, faculty, volunteers, and supporters are dedicated to improving the lives of individuals and families affected by mental illness.

ShapeTX, Board Observer

Shape Therapeutics was founded with the mission to make programmable RNA medicines available for everyone. A dynamic team of scientists, engineers, and problem solvers are dedicated and passionate about making cures a reality.

Previous Board Appointments

Chairman of the Board, PAREXEL International Corp. Biopharma Services / Clinical Research.
Chairman of the Board, The Association of Clinical Research Organizations (ACRO) in 2005 & 2013
Board of Director, Aileron Therapeutics
Board Member, IRIS S.A., Belgium. Now a division of Canon, Inc. Optical Character Recognition Technology.
Board Member, Epidauros Biotechnologie AG, Germany. Now a division of Danaher Corp. Pharmacogenetic and Genotyping Research.
Board Member, Tektagen, Inc. Biosafety and Analytical Testing. Now a division of Charles River Laboratories International, Inc.
Board Member, Next Generation Acquisition Corp. SPAC. Merged with Xos, Inc.
Board Member, Next Generation Acquisition Corp. II. SPAC. Merged with Virgin Orbit.
Board Member, Biomedical Science Careers Program (BSCP). Inner-city Youth Support for the Pursuit of Biomedical Science Careers.